Results 1 to 10 of about 9,391,147 (295)

Long-read single molecule real-time (SMRT) sequencing of GBA1 locus in Gaucher disease national cohort from Argentina reveals high frequency of complex allele underlying severe skeletal phenotypes: Collaborative study from the Argentine Group for Diagnosis and Treatment of Gaucher Disease

open access: goldMolecular Genetics and Metabolism Reports, 2021
Gaucher disease is renowned for extreme phenotypic diversity that does not show consistent genotype/phenotype correlations. In Argentina, a national collaborative group, Grupo Argentino de Diagnóstico y Tratamiento de la Enfermedad de Gaucher, GADTEG ...
Guillermo I. Drelichman   +11 more
doaj   +2 more sources

Gaucher Disease

open access: yesHaematology, 2017
Type 1 Gaucher disease is the most common form of this condition. Type 1 is also called non-neuronopathic Gaucher disease because the brain and spinal cord (the central nervous system) are usually not affected.
G. Petur Nielsen   +5 more
semanticscholar   +4 more sources

Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation

open access: yesBMC Medical Genetics, 2019
Background Gaucher disease is a rare pan-ethnic, lysosomal storage disorder resulting due to beta-Glucosidase (GBA1) gene defect. This leads to the glucocerebrosidase enzyme deficiency and an increased accumulation of undegraded glycolipid ...
Jayesh Sheth   +22 more
doaj   +2 more sources

Gaucher Disease [PDF]

open access: yesEinstein (São Paulo), 2007
Although Gaucher disease is a rare disorder, recent developments in novel means for therapeutic intervention have invigorated both academic research and pharmaceutical industry discovery programmes. The common mutations found in the lysosomal enzyme deficient in Gaucher disease, beta-glucocerebrosidase, earmark these proteins for destruction by the ...
Guilherme Henrique Hencklain Fonseca   +1 more
doaj   +4 more sources

Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease [PDF]

open access: goldHaematologica, 2018
Gaucher disease (GD) is an inherited deficiency of glucocerebrosidase leading to accumulation of glucosylceramide in tissues such as the spleen, liver, and bone marrow.
Thibaud Lefèbvre   +10 more
openalex   +2 more sources

Gaucher disease diagnosed after bone marrow trephine biopsy — a report of two cases

open access: goldFolia Histochemica et Cytobiologica, 2011
The hematologist is at the forefront of specialists to whom patients with Gaucher disease present because of cytopenia and hepatosplenomegaly. Usually, patients with such symptoms have undergone trephine biopsy.
Anna Dmoszyńska   +6 more
doaj   +2 more sources

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background Gaucher disease (GD) is a lysosomal disease caused by mutations in the GBA1 gene, leading to glucosylceramide and glucosylsphingosine accumulation.
Sebile Kilavuz   +16 more
doaj   +2 more sources

Spanish consensus on managing pregnancy in women with Gaucher disease [PDF]

open access: yesOrphanet Journal of Rare Diseases
Gaucher disease can have effects on the development of pregnancy, childbirth, and lactation, with impact on health of both the mother and the newborn.
Enrique J. Calderón   +9 more
doaj   +2 more sources

a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy.

open access: yesPLoS ONE, 2023
It is well established that patients with Gaucher disease, as well as carriers of the disease have an increased risk for developing Parkinson's disease.
Marina Moraitou   +7 more
doaj   +2 more sources

Gaucher Disease and Gaucher Cells

open access: yesTurkish Journal of Hematology, 2015
Sevgi Gözdaşoğlu
doaj   +2 more sources

Home - About - Disclaimer - Privacy